Your browser doesn't support javascript.
loading
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.
Harada, Sakiko; Ando, Miki; Ando, Jun; Ishii, Midori; Yamaguchi, Tomoyuki; Yamazaki, Satoshi; Toyota, Tokuko; Ohara, Kazuo; Ohtaka, Manami; Nakanishi, Mahito; Shin, Chansu; Ota, Yasunori; Nakashima, Kazutaka; Ohshima, Koichi; Imai, Chihaya; Nakazawa, Yozo; Nakauchi, Hiromitsu; Komatsu, Norio.
Afiliación
  • Harada S; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Ando M; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan; Division of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. Electronic address: m-ando@juntendo.ac.jp.
  • Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Ishii M; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Yamaguchi T; Division of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Yamazaki S; Division of Stem Cell Biology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Laboratory of Stem Cell Therapy Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
  • Toyota T; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Ohara K; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Ohtaka M; TOKIWA-Bio, Inc., Tsukuba Center, Ibaraki 305-0047, Japan.
  • Nakanishi M; TOKIWA-Bio, Inc., Tsukuba Center, Ibaraki 305-0047, Japan.
  • Shin C; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
  • Ota Y; Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Nakashima K; Department of Pathology, School of Medicine, Kurume University, Fukuoka 830-0011, Japan.
  • Ohshima K; Department of Pathology, School of Medicine, Kurume University, Fukuoka 830-0011, Japan.
  • Imai C; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
  • Nakazawa Y; Department of Pediatrics, Shinsyu University School of Medicine, Nagano 390-0802, Japan.
  • Nakauchi H; Division of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305-5461, USA. Electronic address: nakauchi
  • Komatsu N; Department of Hematology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Mol Ther ; 30(2): 534-549, 2022 02 02.
Article en En | MEDLINE | ID: mdl-34628050
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Virus de Epstein-Barr / Células Madre Pluripotentes Inducidas / Receptores Quiméricos de Antígenos / Linfoma Límite: Animals Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Virus de Epstein-Barr / Células Madre Pluripotentes Inducidas / Receptores Quiméricos de Antígenos / Linfoma Límite: Animals Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón